Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/26/1998 | EP0859601A2 Prolonged release of gm-csf |
08/26/1998 | EP0859596A2 Gel formulations containing growth factors |
08/26/1998 | EP0859593A2 Treatment for itch of chicken pox |
08/26/1998 | EP0859591A1 Use of at least one no synthase inhibitor for treating sensitive skin |
08/26/1998 | EP0741715B1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
08/26/1998 | EP0668874B1 Lhrh antagonists and intermediate products |
08/26/1998 | EP0563093B1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
08/26/1998 | EP0558603B1 Retroviral protease inhibitors |
08/26/1998 | EP0506757B1 A recombinant human factor viii derivative |
08/26/1998 | EP0479948B1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
08/26/1998 | EP0423326B1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient |
08/26/1998 | CN1191572A Recombinant protein having bacteriophage endosialidase enzymatic activity |
08/26/1998 | CN1191568A Gene switch comprising ecdysone receptor |
08/26/1998 | CN1191567A Macrophage activating factors derived from cloned vitamin D binding protein |
08/26/1998 | CN1191491A 结缔组织生长因子 Connective tissue growth factor |
08/26/1998 | CN1191490A Stable isotonic lyophilized protein formulation |
08/26/1998 | CN1191489A Endoparasiticidal composition |
08/26/1998 | CN1191485A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substd. amino 1, 2, 3-triazoles |
08/26/1998 | CN1191139A Liquid gonadotropin containing formulations |
08/26/1998 | CN1039586C Method for preparing organic salts of N, N'-diacetyl cystine |
08/26/1998 | CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence |
08/25/1998 | US5798448 AL-1 neurotrophic factor antibodies |
08/25/1998 | US5798445 Purified ductal carcinoma antigen |
08/25/1998 | US5798442 Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases |
08/25/1998 | US5798386 Angiogenic lipid formulations |
08/25/1998 | US5798363 Use for tachykinin antagonists to treat emesis |
08/25/1998 | US5798355 Inhibitors of rotamase enzyme activity |
08/25/1998 | US5798352 Antithrombotic amidinotetrahydropyridylalanine derivatives |
08/25/1998 | US5798337 Low molecular weight peptidomimetic growth hormone secretagogues |
08/25/1998 | US5798336 Antimicrobial peptides |
08/25/1998 | US5798335 Administration of peptide t |
08/25/1998 | US5798334 Use of fibrotic growth factor together with antiinflammtory steroid dexamethasone; wound healing agent |
08/25/1998 | US5798333 Cyclosporin dissolved in tocophersolan and hydrophilic solvent; immunosuppressants |
08/25/1998 | US5798332 Inhibiting thrombosis by administering reagent that binds carbohydrate in which sialic acid is linked to galactose or n-acetylgalactosamine through alpha2-6 linkage |
08/25/1998 | US5798265 Encoding rna complementary to message rna; antisense agents |
08/25/1998 | US5798264 Expression vectors, transformed cells |
08/25/1998 | US5798260 Isolated dna segment that codes for adhesin that mediates bacterial colonization of bovine intestines |
08/25/1998 | US5798258 Cart protein and DNA encoding therefor |
08/25/1998 | US5798257 Nucleic acid encoding human MTS-1 protein |
08/25/1998 | US5798249 Human protein disulfide isomerase |
08/25/1998 | US5798248 Recombinant mutant thrombin receptor and related pharmaceuticals |
08/25/1998 | US5798246 Cyclic nucleotide phosphodiesterase |
08/25/1998 | US5798245 Amino acid sequences |
08/25/1998 | US5798243 Bacterial peptide methionine sulfoxide reductase, and adhesion-associated protein, and antibiotic therapies based thereon |
08/25/1998 | US5798241 ATP-diphosphohydrolases |
08/25/1998 | US5798240 Isolated nucleic acid encoding aminoacyl-transfer rna synthetase |
08/25/1998 | US5798239 Culturing a potentiate polypeptide for treating deficiency of iduronate 2-sulfatase |
08/25/1998 | US5798238 Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer |
08/25/1998 | US5798231 Nucleotide sequences for α chain variable regions in human lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
08/25/1998 | US5798229 Bispecific molecules recognizing lymphocyte antigen CD2 and tumor antigens |
08/25/1998 | US5798228 Recombinant production of dog and horse type I interferons |
08/25/1998 | US5798227 Expressing the globulins in the same cell such that alpha and beta globulin-like polypeptides are assembled and combined with heme to produce a hemoglobin-like protein |
08/25/1998 | US5798225 Process for recombinant production of PTH and PTHrp analogs |
08/25/1998 | US5798224 Genetic engineered a cell adhesion proteins |
08/25/1998 | US5798223 Polynucleotides encoding human amine transporter and methods of using the same |
08/25/1998 | US5798216 Using a monoclonal antibody which binds to a glycoprotein ib-alpha polypeptide having a methionine-145 residue but does not bind to the polypeptide having a threonine-145 residue |
08/25/1998 | US5798209 Obtaining a sample containing human nucleic acid sequence encoding human very low density lipoprotein receptor, detecting human nucleic acid sequence by hybridizing it with an oligonuclotide to form a detectable target/probe duplex |
08/25/1998 | US5798208 Walk-through mutagenesis |
08/25/1998 | US5798116 Stabilized materials comprised of copper ion-containing fibronectin mats |
08/25/1998 | US5798113 Grafting a vehicle containing core which contains isolated cells, either suspended in liquid or immobilized within hydrogel matrix, surrounded by a biocompatible jacket which protects isolated cells in core from immunological attack |
08/25/1998 | US5798102 Beta-amyloyd, streptolysin o, growth hormone |
08/25/1998 | US5798100 Multi-stage cascade boosting vaccine |
08/25/1998 | US5798099 Genetic engineering; culture product |
08/25/1998 | US5798090 Enhancement of the cellular immune response |
08/25/1998 | US5797906 Retrograde tissue splitter and method |
08/25/1998 | US5797870 To deliver a gene therapy agent to epicardial/pericardial tissue |
08/25/1998 | CA2224111A1 Novel compounds |
08/25/1998 | CA2137677C Stabilized somatotropin for parenteral administration |
08/25/1998 | CA2117588C Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
08/25/1998 | CA1340012C Peptide determinant associated with immunity |
08/24/1998 | CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor |
08/21/1998 | CA2224085A1 Aroe |
08/21/1998 | CA2223032A1 Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents |
08/20/1998 | WO1998036098A1 Diagnosis and treatment of glaucoma |
08/20/1998 | WO1998036087A1 Immunological tolerance to hiv epitopes |
08/20/1998 | WO1998036077A1 Novel human parvulin-like protein |
08/20/1998 | WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
08/20/1998 | WO1998036074A2 Single and double chain antibodies to the egf receptor, derivates thereof and their use |
08/20/1998 | WO1998036072A1 Neurturin receptor |
08/20/1998 | WO1998036071A1 Novel human cytochrome b5 |
08/20/1998 | WO1998036070A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION |
08/20/1998 | WO1998036069A1 Novel human mago nashi protein |
08/20/1998 | WO1998036068A2 Human p24 vesicle proteins |
08/20/1998 | WO1998036067A2 Secreted proteins and polynucleotides encoding them |
08/20/1998 | WO1998036066A1 An altered telomere repeat binding factor and therapeutic use thereof |
08/20/1998 | WO1998036065A1 Differentiation enhancing factors and uses therefor |
08/20/1998 | WO1998036064A1 Phosphonate binding proteins |
08/20/1998 | WO1998036063A1 Novel h-rev 107-like protein |
08/20/1998 | WO1998036062A1 Neural cell adhesion molecule splicing variants |
08/20/1998 | WO1998036061A2 Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity |
08/20/1998 | WO1998036060A1 Diagnostic and therapeutic use of a polypeptide with ob25 receptor activity expressed by myelin producing cells |
08/20/1998 | WO1998036059A2 Prion propagation inhibition by dominant-negative prion protein mutants |
08/20/1998 | WO1998036057A1 Thymocyte caspase activity and negative selection |
08/20/1998 | WO1998036055A1 Gene therapy for alleviating erectile dysfunction |
08/20/1998 | WO1998036054A1 Novel molecules |
08/20/1998 | WO1998036013A1 Monomers derived from hydroxy acids and polymers prepared therefrom |
08/20/1998 | WO1998035991A1 Modified cytokine receptor protein |
08/20/1998 | WO1998035990A1 cDNA ENCODING NUCLEOSIDE TRANSPORTER |
08/20/1998 | WO1998035986A1 Receptor that binds trail |
08/20/1998 | WO1998035985A1 Protein markers for lung cancer and use thereof |